BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Business

  Nurix Appoints Robert Tjian, Ph.D. Of The Column Group To Its Board Of Directors

  December 7, 2016

   · 

  2 min read
• Business

  Cristal Therapeutics And iTeos Therapeutics Announce Strategic Partnership For The Development Of Immuno-Oncology Therapeutic Candidates Using Cristal’s CriPec Nanotech Platform

  December 7, 2016

   · 

  3 min read
• Policy

  The Amyloidosis Research Consortium, A Patient Led Foundation, Delivers Draft Guidance To FDA For Developing Drugs For AL Amyloidosis

  December 7, 2016

   · 

  3 min read
• Polyganics Announces Birmingham Hand Centre Efficacy Study Of Nerve Conduit Neurolac In Finger Surgery

  December 7, 2016

   · 

  3 min read
• Compugen Ltd. Discloses Its Cancer Immunotherapy Program Targeting TIGIT Immune Checkpoint

  December 7, 2016

   · 

  5 min read
• Pharm Country

  Boehringer Ingelheim Release: Limited Improvement In EGFR Testing Rates Observed In New Survey With Approximately One In Five Advanced Lung Cancer Patients Still At Risk Of Missing Out On Targeted Therapy

  December 7, 2016

   · 

  5 min read
• Business

  Parenteral Drug Association Announces Results Of Board Of Directors Election

  December 7, 2016

   · 

  1 min read
• FDA

  LifeCodexx AG Receives CE Mark For Its Novel NIPT Solution Based On Methylation-Specific Quantitative PCR

  December 7, 2016

   · 

  2 min read
• Business

  Medtronic And Fitbit Partner To Integrate Health And Activity Data Into New CGM Solution For Simplified Type 2 Diabetes Management

  December 7, 2016

   · 

  6 min read
• Drug Development

  TRANSGENE, UC Davis To Conduct Phase II Trial Of The Combination Of TG4010 With Opdivo (Nivolumab) For 2nd Line Treatment Of Metastatic Non-Small Cell Lung Cancer (NSCLC)

  December 7, 2016

   · 

  6 min read